Literature DB >> 21880968

Clinical validation of the cobas 4800 HPV test for cervical screening purposes.

D A M Heideman1, A T Hesselink, J Berkhof, F van Kemenade, W J G Melchers, N Fransen Daalmeijer, M Verkuijten, C J L M Meijer, P J F Snijders.   

Abstract

This study shows that the clinical performance and reproducibility of the cobas 4800 HPV test for high-risk human papillomavirus (HPV) detection fulfill the criteria as formulated in international guidelines of HPV test requirements for cervical screening purposes. Accordingly, the cobas 4800 HPV test can be considered clinically validated for cervical screening.

Entities:  

Mesh：

Year:  2011        PMID： 21880968      PMCID： PMC3209101          DOI： 10.1128/JCM.05552-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

1.  Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening.

Authors:  Dorien C Rijkaart; Johannes Berkhof; Folkert J van Kemenade; Veerle M H Coupe; Albertus T Hesselink; Lawrence Rozendaal; Danielle A M Heideman; Ren H Verheijen; Saskia Bulk; Wim M Verweij; Peter J F Snijders; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2011-05-05       Impact factor: 7.396

2.  Validation of high-risk HPV tests for primary cervical screening.

Authors:  C J L M Meijer; H Berkhof; D A M Heideman; A T Hesselink; P J F Snijders
Journal:  J Clin Virol       Date:  2009-11       Impact factor: 3.168

3.  GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes.

Authors:  Adriaan J C van den Brule; René Pol; Nathalie Fransen-Daalmeijer; Leo M Schouls; Chris J L M Meijer; Peter J F Snijders
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

4.  High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study.

Authors:  Mark H Stoler; Thomas C Wright; Abha Sharma; Raymond Apple; Karen Gutekunst; Teresa L Wright
Journal:  Am J Clin Pathol       Date:  2011-03       Impact factor: 2.493

5.  [Evaluation of a prototype real-time PCR assay for the separate detection of human papilloma virus genotypes 16 and 18 and other high risk human papillomavirus in cervical cancer screening].

Authors:  María Luisa Mateos; Jesús Chacón de Antonio; Mario Rodríguez-Domínguez; Itziar Sanz; María Dolores Rubio
Journal:  Enferm Infecc Microbiol Clin       Date:  2011-03-23       Impact factor: 1.731

6.  Comparison of HPV and cytology triage algorithms for women with borderline or mild dyskaryosis in population-based cervical screening (VUSA-screen study).

Authors:  Dorien C Rijkaart; Johannes Berkhof; Folkert J van Kemenade; Lawrence Rozendaal; René H M Verheijen; Saskia Bulk; Miriam E Herreilers; Wim M Verweij; Peter J F Snijders; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2010-05-01       Impact factor: 7.396

7.  Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping.

Authors:  Philip E Castle; Mark Sadorra; Tiffany Lau; Carrie Aldrich; Francisco A R Garcia; Janet Kornegay
Journal:  J Clin Microbiol       Date:  2009-08-12       Impact factor: 5.948

8.  Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older.

Authors:  Chris J L M Meijer; Johannes Berkhof; Philip E Castle; Albertus T Hesselink; Eduardo L Franco; Guglielmo Ronco; Marc Arbyn; F Xavier Bosch; Jack Cuzick; Joakim Dillner; Daniëlle A M Heideman; Peter J F Snijders
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396
  8 in total
  57 in total

1.  Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix.

Authors:  Simon Grandjean Lapierre; Philippe Sauthier; Marie-Hélène Mayrand; Simon Dufresne; Patrick Petignat; Diane Provencher; Pierre Drouin; Philippe Gauthier; Marie-Josée Dupuis; Bertrand Michon; Stéphan Ouellet; Rachid Hadjeres; Alex Ferenczy; Eduardo L Franco; François Coutlée
Journal:  J Clin Microbiol       Date:  2012-02-01       Impact factor: 5.948

Review 2.  Human Papillomavirus Laboratory Testing: the Changing Paradigm.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

3.  Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening.

Authors:  A T Hesselink; C J L M Meijer; M Poljak; J Berkhof; F J van Kemenade; M L van der Salm; M Bogaarts; P J F Snijders; D A M Heideman
Journal:  J Clin Microbiol       Date:  2013-05-01       Impact factor: 5.948

4.  Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV assay for human papillomavirus genotyping.

Authors:  C Estrade; R Sahli
Journal:  J Clin Microbiol       Date:  2013-12-11       Impact factor: 5.948

5.  Prevalence of Human Papillomavirus Genotypes and Abnormal Pap Smears Among Women in the Military Health System.

Authors:  Christopher M Daly; Shana L Hansen; Paul O Kwon; Timothy A Roberts
Journal:  J Community Health       Date:  2018-06

6.  Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.

Authors:  A T Hesselink; J Berkhof; M L van der Salm; A P van Splunter; T H Geelen; F J van Kemenade; M G B Bleeker; D A M Heideman
Journal:  J Clin Microbiol       Date:  2014-01-03       Impact factor: 5.948

7.  Stability of cervical specimens in SurePath medium for human papillomavirus testing with the Roche cobas 4800 assay.

Authors:  Laura Gilbert; Elizabeth Oates; Samuel Ratnam
Journal:  J Clin Microbiol       Date:  2013-07-31       Impact factor: 5.948

8.  ViroPanel: Hybrid Capture and Massively Parallel Sequencing for Simultaneous Detection and Profiling of Oncogenic Virus Infection and Tumor Genome.

Authors:  Michael K Slevin; Bruce M Wollison; Winslow Powers; Robert T Burns; Neil Patel; Matthew D Ducar; Gabriel J Starrett; Elizabeth P Garcia; Danielle K Manning; Jingwei Cheng; Glenn J Hanna; Kenneth M Kaye; Paul Van Hummelen; Anwesha Nag; Aaron R Thorner; James A DeCaprio; Laura E MacConaill
Journal:  J Mol Diagn       Date:  2020-02-15       Impact factor: 5.568

9.  HPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease.

Authors:  Patricia Luhn; Nicolas Wentzensen
Journal:  Curr Obstet Gynecol Rep       Date:  2013-06-01

10.  Simultaneous detection, genotyping, and quantification of human papillomaviruses by multicolor real-time PCR and melting curve analysis.

Authors:  Yiqun Liao; Yulin Zhou; Qiwei Guo; Xiaoting Xie; Ena Luo; Jian Li; Qingge Li
Journal:  J Clin Microbiol       Date:  2012-11-21       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.